ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "A Risk Stratification Model for Low Stage Uterine leiomyosarcoma"
Episode Synopsis
Uterine leiomyosarcoma is the most common uterine mesenchymal malignancy. The majority present at stage I with variable clinical outcome.
In this episode of ModPath Chat, Dr. David Chapel discusses his recently published multi-institutional study proposing a novel risk stratification model (shown below) for low stage uterine leiomyosarcoma.
Risk score = (coagulative necrosis)(1) + (mitoses > 25 per 2.4mm2)(2) + (atypical mitoses)(2) + (lymphovascular invasion)(3) + (serosal abutment)(5)
In this episode of ModPath Chat, Dr. David Chapel discusses his recently published multi-institutional study proposing a novel risk stratification model (shown below) for low stage uterine leiomyosarcoma.
Risk score = (coagulative necrosis)(1) + (mitoses > 25 per 2.4mm2)(2) + (atypical mitoses)(2) + (lymphovascular invasion)(3) + (serosal abutment)(5)
More episodes of the podcast Springer Nature
Resisting parasitoids: beetle v wasp
26/11/2025
The consequences of invasion
29/10/2025
Older and wiser? The neural correlates of worry induction and reappraisal in older adults
27/10/2025
Genomic responses to past and future change
27/08/2025
July 2025: ECI Katie Strobel
20/08/2025
Colourful signals in Anolis lizards
30/07/2025
In God we trust